Adjuvant corneal crosslinking to prevent hyperopic LASIK regression
Ioannis M Aslanides, Achyut N MukherjeeEmmetropia Mediterranean Eye Clinic, Heraklion, Crete, GreecePurpose: To report the long term outcomes, safety, stability, and efficacy in a pilot series of simultaneous hyperopic laser assisted in situ keratomileusis (LASIK) and corneal crosslinking (CXL).Meth...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c13e13e9bb94c5e9524bd3decab2de1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0c13e13e9bb94c5e9524bd3decab2de1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0c13e13e9bb94c5e9524bd3decab2de12021-12-02T00:42:10ZAdjuvant corneal crosslinking to prevent hyperopic LASIK regression1177-54671177-5483https://doaj.org/article/0c13e13e9bb94c5e9524bd3decab2de12013-03-01T00:00:00Zhttp://www.dovepress.com/adjuvant-corneal-crosslinking-to-prevent-hyperopic-lasik-regression-a12621https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Ioannis M Aslanides, Achyut N MukherjeeEmmetropia Mediterranean Eye Clinic, Heraklion, Crete, GreecePurpose: To report the long term outcomes, safety, stability, and efficacy in a pilot series of simultaneous hyperopic laser assisted in situ keratomileusis (LASIK) and corneal crosslinking (CXL).Method: A small cohort series of five eyes, with clinically suboptimal topography and/or thickness, underwent LASIK surgery with immediate riboflavin application under the flap, followed by UV light irradiation. Postoperative assessment was performed at 1, 3, 6, and 12 months, with late follow up at 4 years, and results were compared with a matched cohort that received LASIK only.Results: The average age of the LASIK-CXL group was 39 years (26–46), and the average spherical equivalent hyperopic refractive error was +3.45 diopters (standard deviation 0.76; range 2.5 to 4.5). All eyes maintained refractive stability over the 4 years. There were no complications related to CXL, and topographic and clinical outcomes were as expected for standard LASIK.Conclusion: This limited series suggests that simultaneous LASIK and CXL for hyperopia is safe. Outcomes of the small cohort suggest that this technique may be promising for ameliorating hyperopic regression, presumed to be biomechanical in origin, and may also address ectasia risk.Keyword: CXLAslanides IMMukherjee ANDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2013, Iss default, Pp 637-641 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ophthalmology RE1-994 |
spellingShingle |
Ophthalmology RE1-994 Aslanides IM Mukherjee AN Adjuvant corneal crosslinking to prevent hyperopic LASIK regression |
description |
Ioannis M Aslanides, Achyut N MukherjeeEmmetropia Mediterranean Eye Clinic, Heraklion, Crete, GreecePurpose: To report the long term outcomes, safety, stability, and efficacy in a pilot series of simultaneous hyperopic laser assisted in situ keratomileusis (LASIK) and corneal crosslinking (CXL).Method: A small cohort series of five eyes, with clinically suboptimal topography and/or thickness, underwent LASIK surgery with immediate riboflavin application under the flap, followed by UV light irradiation. Postoperative assessment was performed at 1, 3, 6, and 12 months, with late follow up at 4 years, and results were compared with a matched cohort that received LASIK only.Results: The average age of the LASIK-CXL group was 39 years (26–46), and the average spherical equivalent hyperopic refractive error was +3.45 diopters (standard deviation 0.76; range 2.5 to 4.5). All eyes maintained refractive stability over the 4 years. There were no complications related to CXL, and topographic and clinical outcomes were as expected for standard LASIK.Conclusion: This limited series suggests that simultaneous LASIK and CXL for hyperopia is safe. Outcomes of the small cohort suggest that this technique may be promising for ameliorating hyperopic regression, presumed to be biomechanical in origin, and may also address ectasia risk.Keyword: CXL |
format |
article |
author |
Aslanides IM Mukherjee AN |
author_facet |
Aslanides IM Mukherjee AN |
author_sort |
Aslanides IM |
title |
Adjuvant corneal crosslinking to prevent hyperopic LASIK regression |
title_short |
Adjuvant corneal crosslinking to prevent hyperopic LASIK regression |
title_full |
Adjuvant corneal crosslinking to prevent hyperopic LASIK regression |
title_fullStr |
Adjuvant corneal crosslinking to prevent hyperopic LASIK regression |
title_full_unstemmed |
Adjuvant corneal crosslinking to prevent hyperopic LASIK regression |
title_sort |
adjuvant corneal crosslinking to prevent hyperopic lasik regression |
publisher |
Dove Medical Press |
publishDate |
2013 |
url |
https://doaj.org/article/0c13e13e9bb94c5e9524bd3decab2de1 |
work_keys_str_mv |
AT aslanidesim adjuvantcornealcrosslinkingtopreventhyperopiclasikregression AT mukherjeean adjuvantcornealcrosslinkingtopreventhyperopiclasikregression |
_version_ |
1718403477443444736 |